Clara Biotech hits $850K in seed funding roundup, preparing to launch first product
June 15, 2021 | Startland News Staff
An emerging biotech startup in the region is reporting a busy spring with a significant seed round already raised and key steps under way to launch its product: a solution that removes manufacturing roadblocks for breakthrough drugs.
“We’re in an exciting and growing space and currently have low regulatory hurdles in the research stage,” said Jim West, co-founder of Clara Biotech, a Lawrence-based company already buoyed by its founding team’s expertise in exosome technologies, pharmaceutical development, engineering and building life science companies.
Elevator pitch: Clara Biotech is building an exosome isolation platform that solves a huge roadblock around manufacturing that helps the entire biopharma industry make future breakthrough drugs that may not otherwise get approved. We founded Clara Biotech to help move exosomes from research to patient.
Jim West, Clara Biotech
“We’re looking for smart money investors who can help us develop our market position, scale the technology and become the platform that companies can use to get exosome therapies to the patients who need them most,” he continued, detailing Clara Biotech’s momentum in a company snapshot update.
Off the heels of announcing an undisclosed investment by Kansas City-based Fountain Innovation Fund, the startup has raised $850,000 for its seed round, West said, with additional investments from angel investors in Boston, San Francisco, India and Kansas City.
Dr. Mei He, Clara Biotech
Clara Biotech recently received a tranche of angel tax credits, still available to qualified investors, he added.
The seed round is expected to help the company debut its beta ExoRelease exosome isolation kit, as well as continue to scale, West said.
Click here to read Clara Biotech’s full snapshot update.
“We are generating revenue and launching our first product,” he said. “At a recent conference for exosome therapeutics, sample preparation quality was the major limiting factor in manufacturing and receiving FDA approval. Our groundbreaking solution resulted in a 70 percent lead conversion rate of all companies attending (which includes investment groups and competitors). We’re currently working with and growing a number of paying early customers including some major pharmaceutical players.”
Founded in 2018 at the Bioscience and Technology Business Center in Lawrence, Clara Biotech’s therapeutic applications range from personalized medicine, targeted drug delivery, immunotherapy, and orphan and rare diseases. It’s solutions are focused on early cancer detection, Alzheimer’s disease, and virus detection.
Click here to learn more about Clara Biotech and how its technology works.
This story is possible thanks to support from the Ewing Marion Kauffman Foundation, a private, nonpartisan foundation that seeks to build inclusive prosperity through a prepared workforce and entrepreneur-focused economic development. The Foundation works to change conditions, address root causes, and break down systemic barriers so that all people – regardless of race, gender, or geography – have the opportunity to achieve economic stability, mobility, and prosperity.
For more information, visit www.kauffman.org and connect with us at www.twitter.com/kauffmanfdn and www.facebook.com/kauffmanfdn.
2021 Startups to Watch
stats here
Related Posts on Startland News
In the field: Industry-specific, hands-free voice tech helps ‘hero up’ data collecting workers
After years of research, Bruce Rasa and his team identified a consistent pain point for field workers: capturing data on-the-go and looping it back to their headquarters. They need a co-pilot, he said, noting the role played by KC-based Dexer (formerly AgVoice), agriculture’s first handsfree data capture service to help cross-industry specialists create records —…
New city flag designed for KC’s now (and tomorrow): Here’s where you’ll see it flying first
Kansas City is ushering in an era of growth and development, Jared Horman said, and the unveiling of a new municipal flag is just the way to recognize this new chapter. “The timing feels particularly exciting with the Chiefs headed to the Super Bowl, the opening of the new terminal at the airport and the…
Pushing without force: Founder credits accelerator’s collaborative ‘in the trenches’ guidance for overseas scaling success
Editor’s note: This article is sponsored by the NMotion startup accelerator, but was independently produced by Startland News. The powerhouse mix of global and localized support David Biga received from the NMotion Growth Accelerator was well worth the program’s required exchange of equity, the proptech startup founder detailed. Particle Space — one of Startland News’…
Coming to the Plaza: Food hall to put ‘chefs out front’ from breakfast to late-night crowd
Just months after expanding to Downtown Kansas City, the Strang Chef Collectives’ next location for a chef-driven food hall will be tailored to fit its new home on the Country Club Plaza, said Shawn Craft. The hall’s four new food and beverage concepts — slated to open in late May or early June — will…